source
- NorthStar Medical Technologies partners with Chinese CRO Quarkmed, while Lonza outlines mid-term guidanceNorthStar Medical Technologies, a maker of radioisotopes, announced a new partnership with Beijing-based contract research organization Quarkmed. Under the agreement, Quarkmed will provide contrac…
- Lakefront Biotherapeutics sells its cell therapy pipeline to Belgian biotech Armed Cell TherapeuticsLakefront Biotherapeutics, formerly known as Galapagos Therapeutics, announced that it has sold its cell therapy pipeline to fellow Belgian biotech Armed Cell Therapeutics. The transferred assets…